Gene · 3488
Papers3,939
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 3,939
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Differential Gene and Protein Expression of Conjunctival Bleb Hyperfibrosis in Early Failure of Glaucoma Surgery. | Int J Mol Sci | 2023 | 37569323 | PubTator, text mining | PubMed |
| Stanniocalcin-2 inhibits skeletal muscle growth and is upregulated in functional overload-induced hypertrophy. | Physiol Rep | 2023 | 37568262 | PubTator, text mining | PubMed |
| Primary and hTERT-Transduced Mesothelioma-Associated Fibroblasts but Not Primary or hTERT-Transduced Mesothelial Cells Stimulate Growth of Human Mesothelioma Cells. | Cells | 2023 | 37566084 | PubTator, text mining | PubMed |
| Intradermal substance P as a challenge agent in healthy individuals. | Clin Transl Sci | 2023 | 37547990 | PubTator, text mining | PubMed |
| Two antisense RNAs-AFAP1-AS1 and MLK7-AS1-promote colorectal cancer progression by sponging miR-149-5p and miR-485-5p. | Mol Ther Nucleic Acids | 2023 | 37547289 | PubTator, text mining | PubMed |
| Multi-omics profiling of CSF from spinal muscular atrophy type 3 patients after nusinersen treatment: a 2-year follow-up multicenter retrospective study. | Cell Mol Life Sci | 2023 | 37543540 | PubTator, text mining | PubMed |
| A Phase Ib/II study of IGF-neutralising antibody xentuzumab with enzalutamide in metastatic castration-resistant prostate cancer. | Br J Cancer | 2023 | 37537253 | PubTator, text mining | PubMed |
| Melatonin supplementation promotes muscle fiber hypertrophy and regulates lipid metabolism of skeletal muscle in weaned piglets. | J Anim Sci | 2023 | 37531568 | PubTator, text mining | PubMed |
| Identification of novel gene signatures and immune cell infiltration in intervertebral disc degeneration using bioinformatics analysis. | Front Mol Biosci | 2023 | 37520321 | PubTator, text mining | PubMed |
| Physiological Approaches Targeting Cellular and Mitochondrial Pathways Underlying Adipose Organ Senescence. | Int J Mol Sci | 2023 | 37511435 | PubTator, text mining | PubMed |
| Bankable human iPSC-derived retinal progenitors represent a valuable source of multipotent cells. | Commun Biol | 2023 | 37479765 | PubTator, text mining | PubMed |
| Investigation of Igf-1, Igf-Bp3 and Igf-Bp5 levels in umbilical cord blood of infants with developmental dysplasia of the hip. | Turk J Med Sci | 2023 | 37476901 | PubTator, text mining | PubMed |
| Therapeutic potential of curcumin and its nanoformulations for treating oral cancer. | World J Methodol | 2023 | 37456978 | PubTator, text mining | PubMed |
| Global Analysis of Transcription Start Sites and Enhancers in Endometrial Stromal Cells and Differences Associated with Endometriosis. | Cells | 2023 | 37443771 | PubTator, text mining | PubMed |
| Angiocrine Signaling in Sinusoidal Health and Disease. | Semin Liver Dis | 2023 | 37442155 | PubTator, text mining | PubMed |
| Identification of diagnostic biomarkers in Alzheimer's disease by integrated bioinformatic analysis and machine learning strategies. | Front Aging Neurosci | 2023 | 37434738 | PubTator, text mining | PubMed |
| Structural basis for specific DNA sequence motif recognition by the TFAP2 transcription factors. | Nucleic Acids Res | 2023 | 37409559 | PubTator, text mining | PubMed |
| Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potential. | Exp Mol Med | 2023 | 37394582 | PubTator, text mining | PubMed |
| Extracellular matrix remodelling and stiffening contributes to tumorigenesis of salivary carcinoma ex pleomorphic adenoma--A study based on patient-derived organoids. | Cell Biosci | 2023 | 37393249 | PubTator, text mining | PubMed |
| A Case Report of Doege-Potter Syndrome: A Rare Cause of Hypoglycemia in a Patient without Diabetes. | J Clin Med | 2023 | 37373678 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3488/papers?page=15